Regulation of the neuroinflammatory response in autoimmune uveitis
自身免疫性葡萄膜炎神经炎症反应的调节
基本信息
- 批准号:10115860
- 负责人:
- 金额:$ 42.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Research Abstract: Autoimmune uveitis is a serious sight-threatening condition defined by an autoreactive
immune response against the retina and uveal tissues. In autoimmune uveitis, the retina and uveal tissues
become a target of autoreactive immune cells, which leads to irreversible neural damages and can progress to
significant visual impairment. Since the retina is a so-called “immune privileged” tissue protected by blood-
retinal barrier, how immune cells gain entry into the retina and what antigen presenting cell (APC) populations
are involved in local antigen presentation have been a long discussion. This proposal describes aims to
elucidate an innovative mechanism whereby retinal microglia mediate autoreactive immune cell entry into the
retina. Microglia are the resident immune cells of the central nervous system, including the retina, and function
in the homeostatic maintenance of the neuro-retinal microenvironment. The role and function of microglia in
disease progression is not well understood due to their multiple phenotypes and/or different stages of
activation that are associated with either harmful or beneficial effects in disease pathogenesis.
Our recent work demonstrated that microglial depletion inhibits development of EAU and that microglia are
essential to disease induction. Interestingly, retinal microglia are significantly activated in response to EAU
disease induction, quickly localizing to the retinal vasculature. However, our data indicated that microglia do
not function as APCs in disease initiation, but in fact function to facilitate infiltration of a variety of circulating
immune cells into the neuroretina. Our data highly suggested that microglia are key population that initiates
blood-retinal barrier breakdown and that the circulating APCs and T cells that enter the retina trigger the
subsequent vision altering auto-inflammatory response. However, the mechanisms by which this occurs
remains unknown.
In this proposal, we will elucidate the mechanism by which autoreactive immune cells gain entry into the retina
and how the subsequent autoimmune response develops during disease progression in a mouse model of
experimental autoimmune uveitis (EAU). We will begin by defining the initiating APC populations in EAU and
the contribution of microglial expression of MHC-II during EAU disease progression. Moreover, we will identify
the activation and kinetics of retinal microglia and infiltrating immune cells in EAU induction by using a single
cell RNA sequence profiling. Lastly, we will define the role of SIRPalpha/CD47, an immune axis that is highly
regulated in EAU and that functions in phagocytosis initiation and immune cell reactivity. Understanding the
mechanism by which microglia initiate autoimmune uveitis will likely open new avenues of therapy for this
disease as well as other blinding neovascular ophthalmic diseases.
研究摘要:自身免疫性葡萄膜炎是一种严重的视力威胁性疾病
对视网膜和紫veal组织的免疫反应。在自身免疫性葡萄膜炎中,视网膜和卵子组织
成为自动反应性免疫电池的目标,这会导致不可逆的神经损害,并可以发展为
重大视觉障碍。由于视网膜是一种由血液保护的所谓“免疫特权”组织
视网膜屏障,免疫细胞如何进入视网膜以及什么抗原呈现细胞(APC)种群
参与局部抗原表现一直是一个漫长的讨论。该提议描述的目的是
阐明一种创新机制,视网膜小胶质细胞介导自动反应性免疫细胞进入
视网膜。小胶质细胞是中枢神经系统的居民,包括视网膜,功能
在神经视网膜微环境的稳态维护中。小胶质细胞在
由于其多种表型和/或不同的阶段,疾病进展尚未得到很好的了解
与疾病发病机理中有害或有益作用相关的激活。
我们最近的工作表明,小胶质部署抑制了EAU的发展,而小胶质细胞是
疾病诱导至关重要。有趣的是,视网膜小胶质细胞可显着激活EAU
疾病诱导,迅速将其定位到视网膜脉管系统中。但是,我们的数据表明小胶质细胞做
在疾病开始中不充当APC,但实际上功能可以促进各种循环的渗透
免疫细胞进入神经素。我们的数据强烈建议小胶质细胞是启动的关键人群
血液 - 视网膜屏障的分解以及进入视网膜的循环APC和T细胞触发
随后的视力改变自动炎症反应。但是,发生这种情况的机制
仍然未知。
在此提案中,我们将阐明自动反应性免疫球进入视网膜的机制
以及如何在疾病进展过程中随后的自身免疫反应发生在小鼠模型中
实验性自身免疫性葡萄膜炎(EAU)。我们将首先定义EAU的启动APC群体和
MHC-II在EAU疾病进展过程中的小胶质表达的贡献。而且,我们将确定
通过使用单个单一
细胞RNA序列分析。最后,我们将定义sirpalpha/cd47的作用,这是一种高度的免疫轴
在EAU中调节,并在吞噬作用和免疫细胞反应性中起作用。了解
小胶质细胞引发自身免疫性葡萄膜炎的机制可能会为此开放新的治疗途径
疾病以及其他盲目的新生血管眼科疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
MEREDITH GREGORY-...的其他基金
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:1037448410374484
- 财政年份:2022
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:1086799010867990
- 财政年份:2022
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:1055014710550147
- 财政年份:2022
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Regulation of the neuroinflammatory response in autoimmune uveitis
自身免疫性葡萄膜炎神经炎症反应的调节
- 批准号:1032006310320063
- 财政年份:2021
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Regulation of the neuroinflammatory response in autoimmune uveitis
自身免疫性葡萄膜炎神经炎症反应的调节
- 批准号:1052737110527371
- 财政年份:2021
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma.
将青光眼中 caspase 8 介导的细胞凋亡与 caspase 8 介导的炎症解偶联。
- 批准号:99195679919567
- 财政年份:2019
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Regulation of vascular leakage in age related macular degeneration
年龄相关性黄斑变性中血管渗漏的调节
- 批准号:83850578385057
- 财政年份:2012
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Regulation of vascular leakage in age related macular degeneration
年龄相关性黄斑变性中血管渗漏的调节
- 批准号:85341348534134
- 财政年份:2012
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
DBA/2J 自发性青光眼模型的神经毒性和神经保护
- 批准号:82376458237645
- 财政年份:2011
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
DBA/2J 自发性青光眼模型的神经毒性和神经保护
- 批准号:83898668389866
- 财政年份:2011
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Role of heat shock transcription factors (HSFs) in hematological malignancies
热休克转录因子(HSF)在血液恶性肿瘤中的作用
- 批准号:1056830710568307
- 财政年份:2023
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Role of Adaptive Immunity in Etiology of Alzheimer’s Disease andAlzheimer’s Disease-Related Dementias
适应性免疫在阿尔茨海默病和阿尔茨海默病相关痴呆病因学中的作用
- 批准号:1051658310516583
- 财政年份:2022
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Role of Adaptive Immunity in Etiology of Alzheimer’s Disease andAlzheimer’s Disease-Related Dementias
适应性免疫在阿尔茨海默病和阿尔茨海默病相关痴呆病因学中的作用
- 批准号:1069803410698034
- 财政年份:2022
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Regulation of the neuroinflammatory response in autoimmune uveitis
自身免疫性葡萄膜炎神经炎症反应的调节
- 批准号:1032006310320063
- 财政年份:2021
- 资助金额:$ 42.5万$ 42.5万
- 项目类别:
Regulation of the neuroinflammatory response in autoimmune uveitis
自身免疫性葡萄膜炎神经炎症反应的调节
- 批准号:1052737110527371
- 财政年份:2021
- 资助金额:$ 42.5万$ 42.5万
- 项目类别: